Blog

Find out more about what is happening at Cmed

Cmed to showcase eSource technology at SCOPE 2018
01 Feb

Cmed to showcase eSource technology at SCOPE 2018

01 Feb 2018

Cmed will demonstrate the eSource and live data analytics capabilities of encapsia®, a next generation clinical data suite, at Summit for Clinical Operations Executives 2018 this month. Cmed’s encapsia® is a cloud-based suite of apps that helps biotech and pharma sponsors transform the way data is captured, monitored and reviewed in clinical trials. Our innovative technology, combined with our experienced people provide real, tangible benefits including an immediacy of being able to see and take actions on your data, and provide reductions in the cost of running a study....

Read post
Cmed’s CEO talks to Innovations in Pharmaceutical Technology.
14 Dec

Cmed’s CEO talks to Innovations in Pharmaceutical Technology.

14 Dec 2017

Cmed’s CEO David Connelly shares his thoughts on how new technology can revolutionise and streamline data and trial processes in this month’s issue of Innovations in Pharmaceutical Technology. Amongst others things, he walks us through the different methodologies used to capture data and how technology is now shaping the way CROs work. Want to learn more? You can read the full article here This article is taken from Innovations in Pharmaceutical Technology January 2018, pages 14-15....

Read post
Looking forward to ASH 2017!
06 Dec

Looking forward to ASH 2017!

06 Dec 2017

The past year in the field of cellular immunotherapy in hematological malignancies has been extremely exciting. We saw FDA approval of the first CAR-T therapy for patients with ALL and then additional approvals for certain types of lymphoma. With several cellular immunotherapy products in development, it is indeed a thrilling time to be involved in the clinical trials of these novel therapies. At the annual American Society of Hematology conference this year, I am looking forward to learning more of recent advances, successes and challenges in developing these therapeutics as we all work together to overcome these hematological diseases that affect so many....

Read post
Cmed to Demonstrate encapsia at Two Leading Oncology Meetings
13 Nov

Cmed to Demonstrate encapsia at Two Leading Oncology Meetings

13 Nov 2017

Cloud-based Clinical Data Suite to be Showcased at Clinical Operations in Oncology Trials Europe and the ASH Annual Meeting Cmed, an oncology focused, innovative technology-led CRO, today announced that it will showcase its encapsia® clinical data suite at two leading oncology meetings, Clinical Operations in Oncology Trials Europe, taking place 5-6 December in Munich, Germany, and the ASH Annual Meeting, taking place 9-12 December in Atlanta, GA. As a full-service CRO, Cmed has a strong reputation in delivering complex and demanding clinical trials across numerous oncology types, including various haematological indications, immuno-oncology, breast, lung, prostate and colorectal....

Read post
Cmed showcasing encapsia at PCT Europe
01 Nov

Cmed showcasing encapsia at PCT Europe

01 Nov 2017

Cmed to Showcase Advanced Data Insights and Analytics Capabilities of encapsia® Clinical Data Suite at Partnerships in Clinical Trials Europe Cmed, an innovative technology-led CRO, will demonstrate its encapsia® clinical data suite at Partnerships in Clinical Trials Europe, taking place 28-29 November 2017 in Amsterdam, The Netherlands. Currently used in trials with nine Pharma companies, including two of the top five, for a variety of electronic data capture (EDC) and direct data capture eSource clinical trials, the solution provides sponsors and their partners with a single point of access for live views of data at any point in a clinical trial....

Read post

Want to learn more?

Please feel free to contact us if you would like to learn more about our skills and experience. We are friendly, open and here to help.

Contact us